Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aptevo Therapeutics Inc
(NQ:
APVO
)
0.1618
-0.0082 (-4.82%)
Streaming Delayed Price
Updated: 3:22 PM EDT, Oct 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
656,059
Open
0.1600
Bid (Size)
0.1618 (9)
Ask (Size)
0.1640 (18)
Prev. Close
0.1700
Today's Range
0.1600 - 0.1780
52wk Range
0.1410 - 21.56
Shares Outstanding
11,523,716
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
September 18, 2024
Via
ACCESSWIRE
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
September 17, 2024
Via
Benzinga
Performance
YTD
-97.93%
-97.93%
1 Month
-50.95%
-50.95%
3 Month
-48.63%
-48.63%
6 Month
-95.65%
-95.65%
1 Year
-98.83%
-98.83%
More News
Read More
Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
September 16, 2024
Via
ACCESSWIRE
Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated
August 13, 2024
Via
ACCESSWIRE
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
May 14, 2024
Via
ACCESSWIRE
Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study
September 16, 2024
Via
ACCESSWIRE
Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024
September 13, 2024
Via
ACCESSWIRE
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024
August 08, 2024
Via
InvestorPlace
Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update
August 08, 2024
Via
ACCESSWIRE
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 18, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 18, 2024
Via
InvestorPlace
Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
July 18, 2024
Via
Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
July 17, 2024
Via
Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 17, 2024
Via
Benzinga
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
July 01, 2024
Via
ACCESSWIRE
Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules
June 28, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 17, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 17, 2024
Via
InvestorPlace
Aptevo Participating in the BIO International Convention
June 03, 2024
Via
ACCESSWIRE
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024
May 08, 2024
Via
InvestorPlace
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update
May 08, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
May 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 02, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
May 02, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.